Effects of Intravascular Administration of Mesenchymal Stromal Cells Derived from Wharton's Jelly of the Umbilical Cord on Systemic Immunomodulation and Neuroinflammation After Traumatic Brain Injury.

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 25, 2024

Primary Completion Date

August 31, 2027

Study Completion Date

March 31, 2028

Conditions

Traumatic Brain Injury

Interventions

DRUG

Mesenchymal Stromal Cells (MSC)

3 injections one week apart

DRUG

placebo

3 injections one week apart

Trial Locations (3)

RECRUITING

Hôpital National d'Instruction des Armées Percy, Clamart

RECRUITING

Beaujon Hospital, Clichy

RECRUITING

Hôpital de la Pitié Salpêtrière - AP-HP, Paris

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER